After a Year of 0.6% Returns, Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Share Price Drop Last Week May Have Less of an Impact on Institutional Investors

Simply Wall StDec 15 22:31

Peering Into Iovance Biotherapeutics's Recent Short Interest

BenzingaDec 6 01:45

Is Iovance Biotherapeutics Stock a Millionaire Maker?

Yahoo FinanceNov 27 19:30

Press Release: Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Dow JonesNov 27 05:01

Express News | Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.d., Ph.d. to Chief Regulatory Officer

BreakingsNov 27 05:01

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Iovance BiotherapeuticsNov 26 13:00